Written Exposure Therapy for Veterans With SUD and PTSD (NCT05327504)
Written Exposure Therapy (WET) as a Brief Trauma Treatment for Veterans With Co-occurring Substance Use Disorders and PTSD
🩺 Plain-English Summary (8th-Grade Level)
The proposed project will evaluate the efficacy of written exposure therapy (WET) among Veterans engaged in substance use disorder (SUD) treatment, who present with co-occurring posttraumatic stress disorder (PTSD). While SUD treatment programs traditionally do not address PTSD, effective trauma treatments have been used successfully among those with substance use comorbidities. WET is a brief trauma-focused intervention shown to effectively treat PTSD. In a recent acceptability and feasibility pilot study among Veterans with co-occurring SUD and PTSD, results showed a decrease in PTSD symptoms among participants receiving WET. The goal of the present study is to improve outcomes for Veterans who present for SUD treatment with comorbid SUD/PTSD.
Who can join: Review the eligibility criteria below.
Location: VA Connecticut Healthcare System West Haven Campus, West Haven, CT — West Haven, Connecticut
Age range: 18 Years
🧪 Interventions in This Study
- Written Exposure Therapy (BEHAVIORAL)
- Neutral Topic Writing (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT — West Haven, Connecticut
📞 Contact the Study Coordinator
Phone: (203) 932-5711
Email: Vera.Bici@va.gov
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Substance Use Disorders
- Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients — Ann Arbor, Michigan
- Ketamine for Methamphetamine Use Disorder — San Leandro, California
- Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life With HIV and Substance Use — Chicago, Illinois
- Evaluation of RRFT for Co-occurring SUD and PTSD Among Teens — Aurora, Colorado
- IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs — The Bronx, New York
- Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults — Farmington, Connecticut
Explore by condition: All Substance Use Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.